The Price of Crossing the Border for Medications

N Engl J Med. 2017 Jul 27;377(4):311-313. doi: 10.1056/NEJMp1704489.

Authors

Michael Fralick¹, Jerry Avorn¹, Aaron S Kesselheim¹

Affiliation

¹ From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (M.F., J.A., A.S.K.); and the University of Toronto Clinician-Scientist Training Program, Toronto (M.F.).

PMID: 28745989
DOI: 10.1056/NEJMp1704489

No abstract available

MeSH terms

Canada
Commerce*
Cost Savings
Drug Costs / legislation & jurisprudence
Drug Industry
Drugs, Generic / economics
Humans
Prescription Drugs / economics*
Prescription Fees / legislation & jurisprudence
Travel
United States

Substances

Drugs, Generic
Prescription Drugs